Found: 7
Select item for more details and to access through your institution.
Characterization and diagnosis spectrum of patients with cerebrospinal fluid pleocytosis.
- Published in:
- Infection, 2024, v. 52, n. 1, p. 219, doi. 10.1007/s15010-023-02087-8
- By:
- Publication type:
- Article
Outcomes of TP53‐mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E232, doi. 10.1002/ajh.26546
- By:
- Publication type:
- Article
Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01000-2
- By:
- Publication type:
- Article
Disparities in receiving disease‐directed therapy, allogeneic stem cell transplantation in non‐Hispanic Black patients with TP53‐mutated acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 6, p. 934, doi. 10.1002/cncr.34604
- By:
- Publication type:
- Article
Are We Moving the Needle for Patients with TP53 -Mutated Acute Myeloid Leukemia?
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2434, doi. 10.3390/cancers14102434
- By:
- Publication type:
- Article
Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211043404
- By:
- Publication type:
- Article